US Patent Issued to Janssen Pharmaceutica on Aug. 5 for "Disubstituted octahydropyrrolo[3,4-cpyrroles as orexin receptor modulators" (California Inventors)

ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,378,254, issued on Aug. 5, was assigned to Janssen Pharmaceutica NV (Beerse, Belgium).

"Disubstituted octahydropyrrolo[3,4-cpyrroles as orexin receptor modulators" was invented by Wenying Chai (San Diego), Michael A. Letavic (San Diego), Kiev S. Ly (San Diego), Daniel J. Pippel (Del Mar, Calif.), Dale A. Rudolph (San Diego), Kathleen C. Sappey (San Diego), Brad M. Savall (San Diego), Chandravadan R. Shah (San Diego), Brock T. Shireman (Poway, Calif.), Akinola Soyode Johnson (San Diego), Emily M. Stocking (Encinitas, Calif.) and Devin M. Swanson (La Jolla, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disubstituted octahydropyrrolo[3,4-c]pyrrole c...